Description:

ODM derived from http://clinicaltrials.gov/show/NCT00185393

Link:

http://clinicaltrials.gov/show/NCT00185393

Keywords:
Versions (2) ▾
  1. 12/9/11
  2. 6/4/17
Uploaded on:

June 4, 2017

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy

Details

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Exclusion Criteria
Back to the top of the page